相关实验视频
Updated: Jul 26, 2026

08:50
Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
39.8K
使用DIBI,一种新型3-基胺-4-一种化剂铁结合聚合物,减轻巨细胞的炎症反应
Javad Ghassemi-Rad1, Wasundara Fernando1, Bruce E Holbein2
1Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
Advanced pharmaceutical bulletin
|June 21, 2023
概括
结合铁的聚合物DIBI通过降低细胞内铁来减少巨细胞中的炎症媒介. 这表明DIBI可以缓和系统性炎症综合征等疾病中的过度炎症反应.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
背景情况:
- 铁对巨细胞在感染期间的炎症反应至关重要.
- 失调的炎症导致各种疾病.
研究的目的:
- 为了研究铁结合聚合物DIBI对巨细胞炎性介质合成的影响.
- 评估DIBI对巨细胞炎症通路的影响.
主要方法:
- 使用了RAW 264.7和骨髓衍生的巨细胞 (BMDMs).
- 用脂多糖 (LPS) 刺激的巨细胞.
- 评估了细胞内可变铁,活性氧物种 (ROS),氧化 (NO),细胞因子产生 (qPCR,ELISA) 和STAT酸化 (西式涂抹).
主要成果:
- 在巨细胞中,DIBI显著降低了细胞内可变铁.
- DIBI抑制了干扰素-β,IL-1β和IL-6的LPS诱导表达,但没有抑制TNF-α.
- DIBI 降低了 ROS 和 NO 的产生,并抑制了 STAT 1 和 3 的酸化.
- 通过添加外源铁来逆转DIBI对IL-6的抑制作用,证实了铁的选择性.
结论:
- 通过结合铁,DIBI有效地减少了巨细胞中的炎症媒介合成.
- 通过DIBI介导的铁剥离可能会减轻系统性炎症综合征等疾病中的过度炎症.
更多相关视频
10:35Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
8.3K
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
8.8K
相关概念视频
Extraction: Advanced Methods
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is formed in...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...